---
title: "This Supernus Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/304886043.md"
description: "Wall Street analysts initiated bullish coverage on several stocks for Monday. B of A Securities rated Iambic Therapeutics (IAM) and Supernus (SUPN) as Buy with targets of $30 and $47, respectively. Baird rated Amaero (AMRO) Outperform with a $9 target. Wells Fargo rated Camping World (CWH) Overweight with a $6 target. Citigroup also initiated a Buy rating on IAM with a $22 target."
datetime: "2026-11-09T16:30:15.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/304886043.md)
  - [en](https://longbridge.com/en/news/304886043.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/304886043.md)
generator: "portal-rs"
---

# This Supernus Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

-   B of A Securities analyst Alec Stranahan initiated coverage on **Iambic Therapeutics, Inc.** (NASDAQ:IAM) with a Buy rating and announced a price target of $30. Iambic Therapeutics closed at $10.17 on Friday. See how other analysts view this stock.
-   Baird analyst Peter Arment initiated coverage on **Amaero Inc.** (NASDAQ:AMRO) with an Outperform rating and announced a price target of $9. Amaero shares closed at $5.45 on Friday. See how other analysts view this stock.
-   Wells Fargo analyst Anthony Bonadio initiated coverage on **Camping World Holdings, Inc.** (NYSE:CWH) with an Overweight rating and announced a price target of $6. Camping World closed at $4.59 on Friday. See how other analysts view this stock.
-   B of A Securities analyst Chi Fong initiated coverage on **Supernus, Inc.** (NASDAQ:SUPN) with a Buy rating and announced a price target of $47. Supernus shares closed at $26.16 on Friday. See how other analysts view this stock.
-   Citigroup analyst Geoff Meacham initiated coverage on **Iambic Therapeutics, Inc.** (NASDAQ:IAM) with a Buy rating and announced a price target of $22. Iambic Therapeutics closed at $10.17 on Friday. See how other analysts view this stock.

Considering buying SUPN stock? Here’s what analysts think:

*Photo via Shutterstock*

### Related Stocks

- [AMRO.US](https://longbridge.com/en/quote/AMRO.US.md)
- [CWH.US](https://longbridge.com/en/quote/CWH.US.md)
- [IAM.US](https://longbridge.com/en/quote/IAM.US.md)
- [SUPN.US](https://longbridge.com/en/quote/SUPN.US.md)

## Related News & Research

- [Iambic Therapeutics, Inc. GAAP EPS of -$8.52 misses by $7.75, revenue of $11.4M beats by $3.11M](https://longbridge.com/en/news/305698417.md)
- [IAM: Pipeline progress and $455M pro forma cash position support planned 2027 milestones](https://longbridge.com/en/news/305676390.md)
- [Bank of America Names 2 'Strong Buy' Stocks With 60%+ Upside](https://longbridge.com/en/news/305294459.md)
- [Wells Fargo initiates coverage of Camping World Holdings at Overweight, sets price target at $6](https://longbridge.com/en/news/304854550.md)
- [AMRO: Revenue climbed 35% YoY as $13.4 million backlog supports production scale-up](https://longbridge.com/en/news/304923101.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**